Systemic Associations with Residual Subretinal Fluid after Ranibizumab in Diabetic Macular Edema

Table 5

Correlating factors for residual subretinal fluid after ranibizumab.

Factor	OR for residual SRF (95% CI)	Adjusted value
Age	0.917 (0.835–1.009)	0.74
Baseline CMT	1.005 (0.997–1.014)	0.218
HbA1c	0.215 (0.117–0.394)	<0.001
Insulin dependence	1.965 (0.242–15.944)	0.527
PRP status
PRP naïve	Reference
PRP beyond 6 months	2.692 (0.175–41.494)	0.478
PRP within 6 months	20.266 (0.908–452.283)	0.058
eGFR	0.093 (0.013–0.644)	0.016

CMT: central macular thickness; DR: diabetic retinopathy, designated as proliferative or nonproliferative diabetic retinopathy; eGFR: estimated glomerular filtration rate; PDR: proliferative diabetic retinopathy; PRP: panretinal photocoagulation; denotes eGFR values categorized to stages as described in Table 2.